Thailand Probes Compulsory License Clopidogrel Purchasing Woes
This article was originally published in PharmAsia News
Executive Summary
Thailand’s Government Pharmaceutical Organization has faced heat from the health ministry over its attempts to buy blood thinner clopidogrel under a compulsory license issued for Sanofi’s Plavix in 2007. The issue is at the heart of the country’s attempts to provide universal health care without costs spiraling out of control.